Hims & Hers Health (HIMS) Stock Price Prediction: Analysts trim targets as the chart tests oversold support
What happened and why it matters
Hims & Hers Health (HIMS) is under pressure near the lower end of its recent range, with the stock at $18.54 after a 3.08% decline over the last 24 hours. The trading range printed between $19.17 and $18.27, while volume on Binance futures was light at $1.19 million, pointing to a pullback that has not yet shown strong participation from the buy side.
The analyst backdrop on November 10, 2026 was mixed but clearly less aggressive than before. Morgan Stanley cut its target to $25 from $28 and kept an Equal-Weight rating. Needham lowered its target to $32 from $42 while staying Buy. Evercore ISI raised its target to $27 from $24 and held an In-Line rating. Jefferies cut its target to $24 from $31 and kept Hold. Canaccord Genuity reiterated Buy and held its $40 target after third-quarter results.
Technical structure is still weak, but oversold conditions are building
The chart remains in a bearish alignment, with the 7-day simple moving average at $19.35 below the 20-day at $23.40 and the 50-day at $26.77. The stock is also trading below both the 12-day EMA at $20.89 and the 26-day EMA at $23.39, which keeps the short- and intermediate-term trend pointed lower.
Momentum is stretched. The 14-day RSI is 29.78, which places HIMS in oversold territory. Stochastic %K at 2.59 and %D at 2.07 reinforce that the stock is deeply compressed. MACD is negative at -2.5012, and the histogram is flat at 0.0000, which suggests downside momentum is still present even if the move is already extended.
Bollinger positioning also matters here: the lower band sits at $16.12, the middle band at $23.40, and %B is 0.1664, which puts the stock close to the lower-band area rather than near the center of the range. That does not guarantee a rebound, but it does show the stock is trading in a technically washed-out zone.
Levels traders will watch
The nearest pivot is $18.66, with immediate resistance at $19.05 and stronger resistance at $19.56. On the downside, immediate support is $18.15 and strong support is $17.76. Daily ATR is $2.09, so the stock has enough volatility to break either side of that band quickly.
The clean read is simple: if HIMS can reclaim the $19.05 to $19.56 area, the market can start treating this as a short-term mean-reversion attempt. If it loses $18.15 and especially $17.76, the lower Bollinger band near $16.12 becomes the next technical reference.
Derivatives positioning is constructive, but not decisive
Binance futures data show neutral funding at 0.0000%, so there is no obvious carry pressure forcing one side of the market. Open interest rose 12.94% over 24 hours to 36,166.27 contracts, which suggests new positioning is building rather than liquidating away.
The long/short ratios lean bullish on Binance, with global accounts at 65.3% long versus 34.7% short and top traders at 67.4% long versus 32.6% short. But the taker buy/sell ratio is 0.6860, with buy volume 263 against sell volume 383, which means aggressive order flow is still skewing to the sell side. That combination usually reads as a market that is positioned for a bounce but has not yet proven that demand is absorbing supply.
Bottom line
HIMS is technically oversold, but the trend is still downward and price remains below every major moving average cited here. The analyst cuts on November 10 narrowed expectations, even as several firms still see materially higher levels than the current share price. For now, the stock looks like a mean-reversion candidate only if it can stabilize above the $18.15 to $17.76 support zone; without that, the bearish structure remains intact.